K. Jensen

Community-associated meticillin-resistant Staphylococcus aureus as a cause of hospital-acquired infections.

R. Skov, K. Jensen, 2009, The Journal of hospital infection.

Cefuroxime pharmacokinetics and pharmacodynamics for intravenous dosage regimens with 750 mg or 1500 mg doses in healthy young volunteers.

D. Hansen, K. Lange, N. Frimodt-Møller, 2020, Journal of medical microbiology.

Microarray-based detection of extended virulence and antimicrobial resistance gene profiles in phylogroup B2 Escherichia coli of human, meat and animal origin.

P. Garneau, J. Harel, G. Bruant, 2011, Journal of medical microbiology.

Impact of low-level fluoroquinolone resistance genes qnrA1, qnrB19 and qnrS1 on ciprofloxacin treatment of isogenic Escherichia coli strains in a murine urinary tract infection model.

P. Nordmann, V. Cattoir, A. Hammerum, 2012, The Journal of antimicrobial chemotherapy.

Intra- and Extracellular Activities of Dicloxacillin against Staphylococcus aureus In Vivo and In Vitro

P. Tulkens, F. Van Bambeke, A. Sandberg, 2010, Antimicrobial Agents and Chemotherapy.

Intra-and Extracellular Activity of Linezolid against Staphylococcus Aureus in Vivo and in Vitro

P. Tulkens, F. Van Bambeke, A. Sandberg, 2009 .

Intra- and extracellular activity of linezolid against Staphylococcus aureus in vivo and in vitro.

P. Tulkens, F. Van Bambeke, K. Jensen, 2010, The Journal of antimicrobial chemotherapy.